Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
OMEROS CORP
Report date June 11, 2021 · Filed February 14, 2022
Section 16 reporting ended · disclosed 2022-02-14. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.81 | Direct | 7,500 |
Reported balance
After 2021-06-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-06-11 · Grant · Acquired 7,500 · Balance 7,500 F1: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 7,500 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 11, 2021. F2: The stock option reported on this Form 4 was scheduled to vest on the day before the date of the issuer's 2022 annual meeting of the shareholders, provided that the reporting person continued to serve as a director of the issuer through such date. The reporting person retired from the issuer's board of directors in October 2021. As a result, the option was terminated without becoming exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 7,500 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 11, 2021.
F2: The stock option reported on this Form 4 was scheduled to vest on the day before the date of the issuer's 2022 annual meeting of the shareholders, provided that the reporting person continued to serve as a director of the issuer through such date. The reporting person retired from the issuer's board of directors in October 2021. As a result, the option was terminated without becoming exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2021 Filed Feb 14, 2022 22:05 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $15.81 | $0.00 |
DisclosureSEC source: 0001415889-22-001298 · form4-02142022_020258.xml · derivative · entry 1 Aspiri Ray · CIK 0001472157 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires not disclosed F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 7,500 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 11, 2021. F2 · derivative.exercise_date: The stock option reported on this Form 4 was scheduled to vest on the day before the date of the issuer's 2022 annual meeting of the shareholders, provided that the reporting person continued to serve as a director of the issuer through such date. The reporting person retired from the issuer's board of directors in October 2021. As a result, the option was terminated without becoming exercisable. F2 · derivative.expiration_date: The stock option reported on this Form 4 was scheduled to vest on the day before the date of the issuer's 2022 annual meeting of the shareholders, provided that the reporting person continued to serve as a director of the issuer through such date. The reporting person retired from the issuer's board of directors in October 2021. As a result, the option was terminated without becoming exercisable. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 23:50 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $14.66 | $0.00 |
DisclosureSEC source: 0001415889-20-001534 · form4-06092020_070605.xml · derivative · entry 1 Aspiri Ray · CIK 0001472157 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2030-06-04 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2021 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 22:52 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $16.87 | $0.00 |
DisclosureSEC source: 0000899243-19-016489 · doc4.xml · derivative · entry 1 Aspiri Ray · CIK 0001472157 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2029-06-06 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2020 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 20:35 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $19.91 | $0.00 |
DisclosureSEC source: 0000899243-18-017006 · doc4.xml · derivative · entry 1 Aspiri Ray · CIK 0001472157 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2028-06-14 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2019 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 16, 2017 Filed Jun 17, 2017 00:00 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $23.75 | $0.00 |
DisclosureSEC source: 0000899243-17-016620 · doc4.xml · derivative · entry 1 Aspiri Ray · CIK 0001472157 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-06-15 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2018 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.